Small Ops Azevan Pharmaceuticals is a tiny firm with 2-10 employees, suggesting a close-knit decision-making process and potential for rapid vendor onboarding, especially for early-stage partnerships or contract development work.

R&D Focus Active development of SRX246 for Huntington's disease neuropsychiatric symptoms indicates a research-driven profile that may need early-stage clinical outsourcing, specialized CROs, or strategic partnerships to advance trials.

Modest Revenue Current revenue is in the low six-figures with a funding cushion of around $2.2M, implying sensitivity to cost-effective solutions, flexible payment terms, and co-development or grant-funded collaboration opportunities.

Tech Stack Utilizes common web and backend technologies (PHP, MySQL, jQuery) and standard deployment stacks, presenting opportunities for cost-efficient IT services, data management tooling, and secure hosting partnerships tailored to small biopharma outfits.

Strategic Fit Potential alignment with CROs, contract manufacturers, or specialized assay developers serving small to mid-size biotechs; emphasis on early-stage clinical development, regulatory consulting, and translational research support could open targeted sales avenues.